Active-comparator design and new-user design in observational studies. - Abstract - Europe PMC
Securing market access with single-arm trial data - IQVIA
Frontiers | Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
PRS Performance Support Tool
Nutrients | Free Full-Text | Postoperative Diet with an Oligomeric Hyperproteic Normocaloric Supplement versus a Supplement with Immunonutrients in Colorectal Cancer Surgery: Results of a Multicenter, Double-Blind, Randomized Clinical Trial
Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis - eBioMedicine
Summary of the main features of suggested EMA rules that should govern... | Download Scientific Diagram
Controls, comparator arms, and designs for critical care comparative effectiveness research: It's complicated - Verity J Ford, Harvey G Klein, Robert L Danner, Willard N Applefeld, Jeffrey Wang, Irene Cortes-Puch, Peter Q
On Biostatistics and Clinical Trials: Synthetic Control Arm (SCA), External Control, Historical Control
Most noninferiority trials were not designed to preserve active comparator treatment effects - ScienceDirect
Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design
Transforming Clinical Trials with Real-World Evidence | BCG
Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical Trials | Journal of the American College of Cardiology
Leveraging external data in the design and analysis of clinical trials in neuro-oncology - The Lancet Oncology
Controls, comparator arms, and designs for critical care comparative effectiveness research: It's complicated - Verity J Ford, Harvey G Klein, Robert L Danner, Willard N Applefeld, Jeffrey Wang, Irene Cortes-Puch, Peter Q
White Paper title goes here
Left: Circuit details of the strong arm latch based comparator. Right:... | Download Scientific Diagram
Securing market access with single-arm trial data - IQVIA
Most noninferiority trials were not designed to preserve active comparator treatment effects - ScienceDirect
Active-comparator arm - RaDaR
Active-comparator design and new-user design in observational studies. - Abstract - Europe PMC
Clinical trial designs of new medicinal products for treating schizophrenia: discussion of EMA's Guideline and a Better Long Term Trial Design
Platform trials and the future of evaluating therapeutic behavioural interventions | Nature Reviews Psychology
Clinical trial overview. CT Computed tomography, CT group Active... | Download Scientific Diagram
![PDF] Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/59e6f477143222b0341e0568c8f08b26f2d8dc27/5-Figure1-1.png "PDF] Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study | Semantic Scholar")
PDF] Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study | Semantic Scholar
Nutrients | Free Full-Text | Postoperative Diet with an Oligomeric Hyperproteic Normocaloric Supplement versus a Supplement with Immunonutrients in Colorectal Cancer Surgery: Results of a Multicenter, Double-Blind, Randomized Clinical Trial
Supplementary Information Treatment Arms Assigned Intervention Supplement: Overview of immunosuppressive therapy in the “CNI-f
